Furthermore, OSM treatment increased the expression of OSMR and IL-1β receptors (IL-1βR) in human RA-FLS and wild-type mouse FLS, which further activated the inflammatory signaling pathway in FLS through positive feedback. This evidence concerns the gene OSMR and rheumatoid arthritis.